nodes	percent_of_prediction	percent_of_DWPC	metapath
Teniposide—Etoposide—sarcoma	0.248	1	CrCtD
Teniposide—Podofilox—Etoposide—sarcoma	0.141	1	CrCrCtD
Teniposide—lung cancer—sarcoma	0.127	1	CtDrD
Teniposide—Topoisomerase Inhibitors—Mitoxantrone—sarcoma	0.112	0.354	CiPCiCtD
Teniposide—Topoisomerase Inhibitors—Etoposide—sarcoma	0.088	0.278	CiPCiCtD
Teniposide—Topoisomerase Inhibitors—Epirubicin—sarcoma	0.0605	0.191	CiPCiCtD
Teniposide—Topoisomerase Inhibitors—Doxorubicin—sarcoma	0.056	0.177	CiPCiCtD
Teniposide—ABCC6—Dactinomycin—sarcoma	0.0285	0.231	CbGbCtD
Teniposide—ABCC6—Etoposide—sarcoma	0.0161	0.131	CbGbCtD
Teniposide—TOP2A—Mitoxantrone—sarcoma	0.0136	0.11	CbGbCtD
Teniposide—TOP2A—Epirubicin—sarcoma	0.011	0.0892	CbGbCtD
Teniposide—ABCC6—Doxorubicin—sarcoma	0.011	0.0891	CbGbCtD
Teniposide—TOP2A—Etoposide—sarcoma	0.00856	0.0695	CbGbCtD
Teniposide—TOP2A—Doxorubicin—sarcoma	0.00584	0.0474	CbGbCtD
Teniposide—ABCG2—Dactinomycin—sarcoma	0.00563	0.0457	CbGbCtD
Teniposide—ABCG2—Mitoxantrone—sarcoma	0.00504	0.0409	CbGbCtD
Teniposide—ABCG2—Vincristine—sarcoma	0.00347	0.0281	CbGbCtD
Teniposide—ABCG2—Etoposide—sarcoma	0.00318	0.0258	CbGbCtD
Teniposide—CYP3A4—Thiotepa—sarcoma	0.00253	0.0205	CbGbCtD
Teniposide—ABCG2—Doxorubicin—sarcoma	0.00217	0.0176	CbGbCtD
Teniposide—CYP3A5—Vincristine—sarcoma	0.00192	0.0156	CbGbCtD
Teniposide—CYP3A5—Etoposide—sarcoma	0.00176	0.0143	CbGbCtD
Teniposide—ABCC6—dermis—sarcoma	0.00155	0.169	CbGeAlD
Teniposide—NCOA3—Validated nuclear estrogen receptor beta network—SMARCB1—sarcoma	0.00112	0.0925	CbGpPWpGaD
Teniposide—CYP3A4—Mitoxantrone—sarcoma	0.00109	0.00883	CbGbCtD
Teniposide—NCOA1—Validated nuclear estrogen receptor beta network—SMARCB1—sarcoma	0.000925	0.0765	CbGpPWpGaD
Teniposide—CYP3A4—Vincristine—sarcoma	0.000749	0.00608	CbGbCtD
Teniposide—TOP2A—Gastric Cancer Network 1—C21orf33—sarcoma	0.000727	0.0601	CbGpPWpGaD
Teniposide—CYP3A4—Etoposide—sarcoma	0.000686	0.00557	CbGbCtD
Teniposide—NCOA1—mammary gland—sarcoma	0.000623	0.0678	CbGeAlD
Teniposide—CYP3A4—Doxorubicin—sarcoma	0.000468	0.0038	CbGbCtD
Teniposide—NCOA1—myometrium—sarcoma	0.000442	0.0481	CbGeAlD
Teniposide—NCOA3—FOXA1 transcription factor network—COL18A1—sarcoma	0.000426	0.0352	CbGpPWpGaD
Teniposide—NCOA1—seminal vesicle—sarcoma	0.000399	0.0435	CbGeAlD
Teniposide—NCOA3—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.000315	0.0261	CbGpPWpGaD
Teniposide—NCOA3—myometrium—sarcoma	0.000308	0.0335	CbGeAlD
Teniposide—NCOA1—Notch-mediated HES/HEY network—TLE1—sarcoma	0.0003	0.0248	CbGpPWpGaD
Teniposide—NCOA1—cardiac atrium—sarcoma	0.000288	0.0314	CbGeAlD
Teniposide—NCOA1—uterus—sarcoma	0.000287	0.0312	CbGeAlD
Teniposide—NCOA1—Notch-mediated HES/HEY network—MYOD1—sarcoma	0.000281	0.0233	CbGpPWpGaD
Teniposide—NCOA3—hematopoietic system—sarcoma	0.000264	0.0288	CbGeAlD
Teniposide—NCOA1—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.000261	0.0216	CbGpPWpGaD
Teniposide—NCOA3—connective tissue—sarcoma	0.000255	0.0277	CbGeAlD
Teniposide—NCOA1—tendon—sarcoma	0.000251	0.0273	CbGeAlD
Teniposide—NCOA1—bone marrow—sarcoma	0.000243	0.0265	CbGeAlD
Teniposide—NCOA3—smooth muscle tissue—sarcoma	0.000233	0.0254	CbGeAlD
Teniposide—ABCC6—hematopoietic system—sarcoma	0.000232	0.0253	CbGeAlD
Teniposide—ABCC6—connective tissue—sarcoma	0.000224	0.0244	CbGeAlD
Teniposide—NCOA1—testis—sarcoma	0.000208	0.0226	CbGeAlD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.000206	0.0171	CbGpPWpGaD
Teniposide—ABCC6—Podofilox—Etoposide—sarcoma	0.000206	0.274	CbGdCrCtD
Teniposide—NCOA3—cardiac atrium—sarcoma	0.000201	0.0219	CbGeAlD
Teniposide—NCOA3—uterus—sarcoma	0.0002	0.0217	CbGeAlD
Teniposide—NCOA1—liver—sarcoma	0.000197	0.0214	CbGeAlD
Teniposide—NCOA1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000192	0.0159	CbGpPWpGaD
Teniposide—NCOA3—lymphoid tissue—sarcoma	0.000186	0.0203	CbGeAlD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—MYOD1—sarcoma	0.000182	0.015	CbGpPWpGaD
Teniposide—TOP2A—myometrium—sarcoma	0.000181	0.0197	CbGeAlD
Teniposide—NCOA3—tendon—sarcoma	0.000175	0.0191	CbGeAlD
Teniposide—NCOA3—bone marrow—sarcoma	0.000169	0.0185	CbGeAlD
Teniposide—NCOA1—lymph node—sarcoma	0.000151	0.0164	CbGeAlD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000146	0.012	CbGpPWpGaD
Teniposide—NCOA3—testis—sarcoma	0.000145	0.0158	CbGeAlD
Teniposide—NCOA3—Idarubicin—Epirubicin—sarcoma	0.000142	0.189	CbGdCrCtD
Teniposide—NCOA3—liver—sarcoma	0.000137	0.0149	CbGeAlD
Teniposide—NCOA1—Leptin signaling pathway—PLCG1—sarcoma	0.000137	0.0113	CbGpPWpGaD
Teniposide—NCOA3—Idarubicin—Doxorubicin—sarcoma	0.000131	0.175	CbGdCrCtD
Teniposide—NCOA1—Regulation of Androgen receptor activity—FOXO1—sarcoma	0.000128	0.0106	CbGpPWpGaD
Teniposide—ABCC6—liver—sarcoma	0.00012	0.0131	CbGeAlD
Teniposide—TOP2A—uterus—sarcoma	0.000117	0.0128	CbGeAlD
Teniposide—NCOA1—Notch-mediated HES/HEY network—KDR—sarcoma	0.000117	0.00966	CbGpPWpGaD
Teniposide—CYP2C9—mammary gland—sarcoma	0.000116	0.0126	CbGeAlD
Teniposide—NCOA1—Transcriptional activation of mitochondrial biogenesis—CREB1—sarcoma	0.000106	0.00877	CbGpPWpGaD
Teniposide—NCOA3—lymph node—sarcoma	0.000105	0.0114	CbGeAlD
Teniposide—TOP2A—tendon—sarcoma	0.000103	0.0112	CbGeAlD
Teniposide—NCOA3—Androgen receptor signaling pathway—FOXO1—sarcoma	0.000102	0.00847	CbGpPWpGaD
Teniposide—TOP2A—bone marrow—sarcoma	9.94e-05	0.0108	CbGeAlD
Teniposide—NCOA1—Leptin signaling pathway—FOXO1—sarcoma	9.71e-05	0.00803	CbGpPWpGaD
Teniposide—NCOA3—FOXA1 transcription factor network—JUN—sarcoma	9.38e-05	0.00776	CbGpPWpGaD
Teniposide—NCOA1—Mitochondrial biogenesis—CREB1—sarcoma	9.16e-05	0.00758	CbGpPWpGaD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	9.13e-05	0.00755	CbGpPWpGaD
Teniposide—CYP2C19—hematopoietic system—sarcoma	9.11e-05	0.00992	CbGeAlD
Teniposide—NCOA1—Circadian Clock—CREB1—sarcoma	9.03e-05	0.00747	CbGpPWpGaD
Teniposide—ABCG2—myometrium—sarcoma	9.01e-05	0.0098	CbGeAlD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—ATF1—sarcoma	8.98e-05	0.00743	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—PLCG1—sarcoma	8.94e-05	0.00739	CbGpPWpGaD
Teniposide—TOP2A—testis—sarcoma	8.5e-05	0.00925	CbGeAlD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—ATF1—sarcoma	8.49e-05	0.00702	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—FOXO1—sarcoma	8.47e-05	0.00701	CbGpPWpGaD
Teniposide—ABCG2—HIF-2-alpha transcription factor network—FLT1—sarcoma	8.47e-05	0.007	CbGpPWpGaD
Teniposide—Phlebitis—Etoposide—sarcoma	8.38e-05	0.00384	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—MYOG—sarcoma	8.38e-05	0.00693	CbGpPWpGaD
Teniposide—Bone marrow depression—Epirubicin—sarcoma	8.26e-05	0.00378	CcSEcCtD
Teniposide—Pancytopenia—Thiotepa—sarcoma	8.25e-05	0.00378	CcSEcCtD
Teniposide—Pancytopenia—Dactinomycin—sarcoma	8.19e-05	0.00375	CcSEcCtD
Teniposide—ABCG2—seminal vesicle—sarcoma	8.14e-05	0.00886	CbGeAlD
Teniposide—Neutropenia—Dactinomycin—sarcoma	8.06e-05	0.00369	CcSEcCtD
Teniposide—ABCG2—Fluoropyrimidine Activity—SMUG1—sarcoma	7.84e-05	0.00648	CbGpPWpGaD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—CREB1—sarcoma	7.8e-05	0.00645	CbGpPWpGaD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	7.7e-05	0.00637	CbGpPWpGaD
Teniposide—NCOA1—Regulation of Androgen receptor activity—MDM2—sarcoma	7.69e-05	0.00636	CbGpPWpGaD
Teniposide—Bone marrow depression—Doxorubicin—sarcoma	7.64e-05	0.0035	CcSEcCtD
Teniposide—Stomatitis—Thiotepa—sarcoma	7.55e-05	0.00346	CcSEcCtD
Teniposide—Stomatitis—Dactinomycin—sarcoma	7.49e-05	0.00343	CcSEcCtD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	7.49e-05	0.0062	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—CREB1—sarcoma	7.43e-05	0.00614	CbGpPWpGaD
Teniposide—Pancytopenia—Vincristine—sarcoma	7.32e-05	0.00335	CcSEcCtD
Teniposide—Neutropenia—Vincristine—sarcoma	7.2e-05	0.0033	CcSEcCtD
Teniposide—CYP3A5—hematopoietic system—sarcoma	7.18e-05	0.00781	CbGeAlD
Teniposide—Pancytopenia—Mitoxantrone—sarcoma	7.12e-05	0.00326	CcSEcCtD
Teniposide—CYP2C9—hematopoietic system—sarcoma	7.06e-05	0.00769	CbGeAlD
Teniposide—NCOA1—Leptin signaling pathway—CREB1—sarcoma	7.04e-05	0.00583	CbGpPWpGaD
Teniposide—Neutropenia—Mitoxantrone—sarcoma	7.02e-05	0.00321	CcSEcCtD
Teniposide—Haemoglobin—Thiotepa—sarcoma	6.99e-05	0.0032	CcSEcCtD
Teniposide—NCOA3—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	6.97e-05	0.00576	CbGpPWpGaD
Teniposide—Haemorrhage—Thiotepa—sarcoma	6.95e-05	0.00319	CcSEcCtD
Teniposide—NCOA3—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	6.95e-05	0.00575	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—MYOG—sarcoma	6.93e-05	0.00573	CbGpPWpGaD
Teniposide—Neuropathy peripheral—Vincristine—sarcoma	6.73e-05	0.00308	CcSEcCtD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	6.72e-05	0.00556	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—FOXO1—sarcoma	6.71e-05	0.00555	CbGpPWpGaD
Teniposide—Stomatitis—Vincristine—sarcoma	6.7e-05	0.00307	CcSEcCtD
Teniposide—NCOA1—Regulation of Androgen receptor activity—JUN—sarcoma	6.69e-05	0.00553	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—NPM1—sarcoma	6.66e-05	0.00551	CbGpPWpGaD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	6.62e-05	0.00548	CbGpPWpGaD
Teniposide—Sweating—Vincristine—sarcoma	6.59e-05	0.00302	CcSEcCtD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—CREB1—sarcoma	6.56e-05	0.00542	CbGpPWpGaD
Teniposide—Stomatitis—Mitoxantrone—sarcoma	6.52e-05	0.00299	CcSEcCtD
Teniposide—Sweating—Mitoxantrone—sarcoma	6.41e-05	0.00294	CcSEcCtD
Teniposide—Flushing—Dactinomycin—sarcoma	6.41e-05	0.00293	CcSEcCtD
Teniposide—Extravasation—Epirubicin—sarcoma	6.39e-05	0.00293	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—EZR—sarcoma	6.35e-05	0.00525	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—FOXO1—sarcoma	6.34e-05	0.00524	CbGpPWpGaD
Teniposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	6.32e-05	0.00523	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—FOXO1—sarcoma	6.26e-05	0.00517	CbGpPWpGaD
Teniposide—Chills—Thiotepa—sarcoma	6.24e-05	0.00286	CcSEcCtD
Teniposide—Arrhythmia—Thiotepa—sarcoma	6.21e-05	0.00285	CcSEcCtD
Teniposide—Chills—Dactinomycin—sarcoma	6.19e-05	0.00284	CcSEcCtD
Teniposide—TOP2A—lymph node—sarcoma	6.16e-05	0.00671	CbGeAlD
Teniposide—NCOA3—Androgen receptor signaling pathway—MDM2—sarcoma	6.14e-05	0.00508	CbGpPWpGaD
Teniposide—Alopecia—Thiotepa—sarcoma	6.14e-05	0.00282	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—CREB1—sarcoma	6.14e-05	0.00508	CbGpPWpGaD
Teniposide—Bronchospasm—Etoposide—sarcoma	6.14e-05	0.00281	CcSEcCtD
Teniposide—Alopecia—Dactinomycin—sarcoma	6.1e-05	0.00279	CcSEcCtD
Teniposide—Haemoglobin—Mitoxantrone—sarcoma	6.04e-05	0.00276	CcSEcCtD
Teniposide—Haemorrhage—Mitoxantrone—sarcoma	6.01e-05	0.00275	CcSEcCtD
Teniposide—NCOA1—Regulation of Androgen receptor activity—SRC—sarcoma	6e-05	0.00496	CbGpPWpGaD
Teniposide—Pancytopenia—Etoposide—sarcoma	5.93e-05	0.00271	CcSEcCtD
Teniposide—Extravasation—Doxorubicin—sarcoma	5.91e-05	0.00271	CcSEcCtD
Teniposide—TOP2A—Vindesine—Vincristine—sarcoma	5.91e-05	0.0789	CbGdCrCtD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	5.89e-05	0.00487	CbGpPWpGaD
Teniposide—ABCG2—uterus—sarcoma	5.84e-05	0.00636	CbGeAlD
Teniposide—Neutropenia—Etoposide—sarcoma	5.84e-05	0.00267	CcSEcCtD
Teniposide—NCOA1—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	5.76e-05	0.00477	CbGpPWpGaD
Teniposide—NCOA1—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	5.75e-05	0.00476	CbGpPWpGaD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—JUN—sarcoma	5.61e-05	0.00464	CbGpPWpGaD
Teniposide—Anaemia—Thiotepa—sarcoma	5.59e-05	0.00256	CcSEcCtD
Teniposide—NCOA3—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	5.59e-05	0.00462	CbGpPWpGaD
Teniposide—Agitation—Thiotepa—sarcoma	5.56e-05	0.00255	CcSEcCtD
Teniposide—Anaemia—Dactinomycin—sarcoma	5.55e-05	0.00254	CcSEcCtD
Teniposide—Neuropathy peripheral—Etoposide—sarcoma	5.45e-05	0.0025	CcSEcCtD
Teniposide—Alopecia—Vincristine—sarcoma	5.45e-05	0.0025	CcSEcCtD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—MDM2—sarcoma	5.43e-05	0.00449	CbGpPWpGaD
Teniposide—Stomatitis—Etoposide—sarcoma	5.42e-05	0.00248	CcSEcCtD
Teniposide—Leukopenia—Thiotepa—sarcoma	5.42e-05	0.00248	CcSEcCtD
Teniposide—TOP2A—Gastric Cancer Network 2—CTNNB1—sarcoma	5.4e-05	0.00447	CbGpPWpGaD
Teniposide—Chills—Mitoxantrone—sarcoma	5.39e-05	0.00247	CcSEcCtD
Teniposide—CYP3A4—hematopoietic system—sarcoma	5.39e-05	0.00586	CbGeAlD
Teniposide—Leukopenia—Dactinomycin—sarcoma	5.38e-05	0.00246	CcSEcCtD
Teniposide—Arrhythmia—Mitoxantrone—sarcoma	5.36e-05	0.00246	CcSEcCtD
Teniposide—NCOA3—Androgen receptor signaling pathway—CCND1—sarcoma	5.35e-05	0.00443	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—JUN—sarcoma	5.34e-05	0.00442	CbGpPWpGaD
Teniposide—Alopecia—Mitoxantrone—sarcoma	5.31e-05	0.00243	CcSEcCtD
Teniposide—NCOA3—Androgen receptor signaling pathway—CTNNB1—sarcoma	5.3e-05	0.00438	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—EZR—sarcoma	5.25e-05	0.00434	CbGpPWpGaD
Teniposide—Neuropathy—Epirubicin—sarcoma	5.23e-05	0.0024	CcSEcCtD
Teniposide—Hypertension—Thiotepa—sarcoma	5.23e-05	0.00239	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—MYOD1—sarcoma	5.18e-05	0.00428	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—MDM2—sarcoma	5.08e-05	0.0042	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—CCND1—sarcoma	5.08e-05	0.0042	CbGpPWpGaD
Teniposide—Neoplasm—Epirubicin—sarcoma	5.04e-05	0.00231	CcSEcCtD
Teniposide—Confusional state—Thiotepa—sarcoma	4.98e-05	0.00228	CcSEcCtD
Teniposide—Anaemia—Vincristine—sarcoma	4.96e-05	0.00227	CcSEcCtD
Teniposide—ABCG2—bone marrow—sarcoma	4.96e-05	0.0054	CbGeAlD
Teniposide—Agitation—Vincristine—sarcoma	4.93e-05	0.00226	CcSEcCtD
Teniposide—Infection—Thiotepa—sarcoma	4.91e-05	0.00225	CcSEcCtD
Teniposide—Oedema—Dactinomycin—sarcoma	4.9e-05	0.00225	CcSEcCtD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	4.9e-05	0.00405	CbGpPWpGaD
Teniposide—ABCG2—HIF-2-alpha transcription factor network—KDR—sarcoma	4.88e-05	0.00404	CbGpPWpGaD
Teniposide—Infection—Dactinomycin—sarcoma	4.87e-05	0.00223	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CREB1—sarcoma	4.87e-05	0.00402	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—IL2—sarcoma	4.85e-05	0.00401	CbGpPWpGaD
Teniposide—Neuropathy—Doxorubicin—sarcoma	4.84e-05	0.00222	CcSEcCtD
Teniposide—Sepsis—Epirubicin—sarcoma	4.84e-05	0.00222	CcSEcCtD
Teniposide—Thrombocytopenia—Thiotepa—sarcoma	4.84e-05	0.00222	CcSEcCtD
Teniposide—Anaemia—Mitoxantrone—sarcoma	4.83e-05	0.00221	CcSEcCtD
Teniposide—Tachycardia—Thiotepa—sarcoma	4.82e-05	0.00221	CcSEcCtD
Teniposide—Leukopenia—Vincristine—sarcoma	4.8e-05	0.0022	CcSEcCtD
Teniposide—Thrombocytopenia—Dactinomycin—sarcoma	4.8e-05	0.0022	CcSEcCtD
Teniposide—NCOA3—Androgen receptor signaling pathway—SRC—sarcoma	4.79e-05	0.00396	CbGpPWpGaD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	4.76e-05	0.00394	CbGpPWpGaD
Teniposide—CYP2C19—liver—sarcoma	4.72e-05	0.00514	CbGeAlD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—JUN—sarcoma	4.72e-05	0.0039	CbGpPWpGaD
Teniposide—Anorexia—Thiotepa—sarcoma	4.71e-05	0.00216	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—CXCR4—sarcoma	4.7e-05	0.00389	CbGpPWpGaD
Teniposide—Phlebitis—Epirubicin—sarcoma	4.7e-05	0.00215	CcSEcCtD
Teniposide—Leukopenia—Mitoxantrone—sarcoma	4.68e-05	0.00214	CcSEcCtD
Teniposide—Anorexia—Dactinomycin—sarcoma	4.67e-05	0.00214	CcSEcCtD
Teniposide—Neoplasm—Doxorubicin—sarcoma	4.66e-05	0.00214	CcSEcCtD
Teniposide—Flushing—Etoposide—sarcoma	4.64e-05	0.00212	CcSEcCtD
Teniposide—Hypertension—Vincristine—sarcoma	4.63e-05	0.00212	CcSEcCtD
Teniposide—Hepatic function abnormal—Epirubicin—sarcoma	4.63e-05	0.00212	CcSEcCtD
Teniposide—NCOA1—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	4.62e-05	0.00382	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—CREB1—sarcoma	4.6e-05	0.0038	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—SRC—sarcoma	4.54e-05	0.00376	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—CREB1—sarcoma	4.54e-05	0.00375	CbGpPWpGaD
Teniposide—Hypertension—Mitoxantrone—sarcoma	4.51e-05	0.00207	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	4.51e-05	0.00373	CbGpPWpGaD
Teniposide—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—sarcoma	4.49e-05	0.00371	CbGpPWpGaD
Teniposide—Chills—Etoposide—sarcoma	4.48e-05	0.00205	CcSEcCtD
Teniposide—Sepsis—Doxorubicin—sarcoma	4.48e-05	0.00205	CcSEcCtD
Teniposide—Chest pain—Mitoxantrone—sarcoma	4.45e-05	0.00204	CcSEcCtD
Teniposide—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	4.44e-05	0.00367	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—CCND1—sarcoma	4.43e-05	0.00366	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—JUN—sarcoma	4.42e-05	0.00365	CbGpPWpGaD
Teniposide—Alopecia—Etoposide—sarcoma	4.41e-05	0.00202	CcSEcCtD
Teniposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	4.4e-05	0.00364	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—CTNNB1—sarcoma	4.38e-05	0.00363	CbGpPWpGaD
Teniposide—Oedema—Vincristine—sarcoma	4.38e-05	0.00201	CcSEcCtD
Teniposide—TOP2A—Gastric Cancer Network 2—MYC—sarcoma	4.38e-05	0.00362	CbGpPWpGaD
Teniposide—Infection—Vincristine—sarcoma	4.35e-05	0.00199	CcSEcCtD
Teniposide—Phlebitis—Doxorubicin—sarcoma	4.35e-05	0.00199	CcSEcCtD
Teniposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	4.33e-05	0.00358	CbGpPWpGaD
Teniposide—Confusional state—Mitoxantrone—sarcoma	4.3e-05	0.00197	CcSEcCtD
Teniposide—Decreased appetite—Thiotepa—sarcoma	4.29e-05	0.00197	CcSEcCtD
Teniposide—Thrombocytopenia—Vincristine—sarcoma	4.29e-05	0.00196	CcSEcCtD
Teniposide—Hepatic function abnormal—Doxorubicin—sarcoma	4.29e-05	0.00196	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—MYOD1—sarcoma	4.28e-05	0.00354	CbGpPWpGaD
Teniposide—TOP2A—Gastric Cancer Network 2—EGFR—sarcoma	4.28e-05	0.00354	CbGpPWpGaD
Teniposide—Oedema—Mitoxantrone—sarcoma	4.27e-05	0.00195	CcSEcCtD
Teniposide—Decreased appetite—Dactinomycin—sarcoma	4.26e-05	0.00195	CcSEcCtD
Teniposide—Infection—Mitoxantrone—sarcoma	4.24e-05	0.00194	CcSEcCtD
Teniposide—ABCG2—testis—sarcoma	4.24e-05	0.00461	CbGeAlD
Teniposide—Hyperhidrosis—Vincristine—sarcoma	4.24e-05	0.00194	CcSEcCtD
Teniposide—NCOA3—Androgen receptor signaling pathway—EGFR—sarcoma	4.2e-05	0.00347	CbGpPWpGaD
Teniposide—Thrombocytopenia—Mitoxantrone—sarcoma	4.18e-05	0.00191	CcSEcCtD
Teniposide—Anorexia—Vincristine—sarcoma	4.18e-05	0.00191	CcSEcCtD
Teniposide—Tachycardia—Mitoxantrone—sarcoma	4.16e-05	0.00191	CcSEcCtD
Teniposide—NCOA1—Organelle biogenesis and maintenance—CREB1—sarcoma	4.16e-05	0.00344	CbGpPWpGaD
Teniposide—Hyperhidrosis—Mitoxantrone—sarcoma	4.12e-05	0.00189	CcSEcCtD
Teniposide—Hypotension—Vincristine—sarcoma	4.09e-05	0.00188	CcSEcCtD
Teniposide—Feeling abnormal—Thiotepa—sarcoma	4.07e-05	0.00187	CcSEcCtD
Teniposide—Anorexia—Mitoxantrone—sarcoma	4.07e-05	0.00186	CcSEcCtD
Teniposide—Feeling abnormal—Dactinomycin—sarcoma	4.04e-05	0.00185	CcSEcCtD
Teniposide—Gastrointestinal pain—Thiotepa—sarcoma	4.04e-05	0.00185	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—MDM2—sarcoma	4.03e-05	0.00333	CbGpPWpGaD
Teniposide—Anaemia—Etoposide—sarcoma	4.02e-05	0.00184	CcSEcCtD
Teniposide—Gastrointestinal pain—Dactinomycin—sarcoma	4.01e-05	0.00184	CcSEcCtD
Teniposide—ABCG2—liver—sarcoma	4.01e-05	0.00436	CbGeAlD
Teniposide—Hypotension—Mitoxantrone—sarcoma	3.99e-05	0.00183	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—SRC—sarcoma	3.96e-05	0.00328	CbGpPWpGaD
Teniposide—Urticaria—Thiotepa—sarcoma	3.92e-05	0.0018	CcSEcCtD
Teniposide—Abdominal pain—Thiotepa—sarcoma	3.91e-05	0.00179	CcSEcCtD
Teniposide—Body temperature increased—Thiotepa—sarcoma	3.91e-05	0.00179	CcSEcCtD
Teniposide—Leukopenia—Etoposide—sarcoma	3.89e-05	0.00178	CcSEcCtD
Teniposide—Body temperature increased—Dactinomycin—sarcoma	3.88e-05	0.00178	CcSEcCtD
Teniposide—Abdominal pain—Dactinomycin—sarcoma	3.88e-05	0.00178	CcSEcCtD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	3.83e-05	0.00317	CbGpPWpGaD
Teniposide—Decreased appetite—Vincristine—sarcoma	3.81e-05	0.00174	CcSEcCtD
Teniposide—Dyspnoea—Mitoxantrone—sarcoma	3.8e-05	0.00174	CcSEcCtD
Teniposide—Hypertension—Etoposide—sarcoma	3.75e-05	0.00172	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—PTPRC—sarcoma	3.74e-05	0.0031	CbGpPWpGaD
Teniposide—Liver function test abnormal—Epirubicin—sarcoma	3.74e-05	0.00171	CcSEcCtD
Teniposide—TOP2A—Vinorelbine—Vincristine—sarcoma	3.73e-05	0.0498	CbGdCrCtD
Teniposide—TOP2A—Podofilox—Etoposide—sarcoma	3.73e-05	0.0497	CbGdCrCtD
Teniposide—CYP3A5—liver—sarcoma	3.72e-05	0.00405	CbGeAlD
Teniposide—CYP2C19—Melatonin metabolism and effects—FOXO1—sarcoma	3.71e-05	0.00307	CbGpPWpGaD
Teniposide—Decreased appetite—Mitoxantrone—sarcoma	3.71e-05	0.0017	CcSEcCtD
Teniposide—Chest pain—Etoposide—sarcoma	3.7e-05	0.0017	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—PLCG1—sarcoma	3.66e-05	0.00303	CbGpPWpGaD
Teniposide—CYP2C9—liver—sarcoma	3.66e-05	0.00398	CbGeAlD
Teniposide—Hypersensitivity—Thiotepa—sarcoma	3.64e-05	0.00167	CcSEcCtD
Teniposide—Hypersensitivity—Dactinomycin—sarcoma	3.61e-05	0.00165	CcSEcCtD
Teniposide—TOP2A—Gastric Cancer Network 2—TP53—sarcoma	3.59e-05	0.00297	CbGpPWpGaD
Teniposide—Gastrointestinal pain—Vincristine—sarcoma	3.58e-05	0.00164	CcSEcCtD
Teniposide—Confusional state—Etoposide—sarcoma	3.58e-05	0.00164	CcSEcCtD
Teniposide—NCOA1—Gene Expression—FUS—sarcoma	3.55e-05	0.00293	CbGpPWpGaD
Teniposide—Asthenia—Thiotepa—sarcoma	3.54e-05	0.00162	CcSEcCtD
Teniposide—Infection—Etoposide—sarcoma	3.53e-05	0.00162	CcSEcCtD
Teniposide—Asthenia—Dactinomycin—sarcoma	3.52e-05	0.00161	CcSEcCtD
Teniposide—Feeling abnormal—Mitoxantrone—sarcoma	3.52e-05	0.00161	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CCND1—sarcoma	3.51e-05	0.0029	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—JUN—sarcoma	3.5e-05	0.00289	CbGpPWpGaD
Teniposide—Pruritus—Thiotepa—sarcoma	3.5e-05	0.0016	CcSEcCtD
Teniposide—Gastrointestinal pain—Mitoxantrone—sarcoma	3.49e-05	0.0016	CcSEcCtD
Teniposide—Thrombocytopenia—Etoposide—sarcoma	3.47e-05	0.00159	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—EGFR—sarcoma	3.47e-05	0.00287	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	3.47e-05	0.00287	CbGpPWpGaD
Teniposide—Tachycardia—Etoposide—sarcoma	3.46e-05	0.00159	CcSEcCtD
Teniposide—Body temperature increased—Vincristine—sarcoma	3.46e-05	0.00159	CcSEcCtD
Teniposide—Abdominal pain—Vincristine—sarcoma	3.46e-05	0.00159	CcSEcCtD
Teniposide—Liver function test abnormal—Doxorubicin—sarcoma	3.46e-05	0.00158	CcSEcCtD
Teniposide—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	3.43e-05	0.00284	CbGpPWpGaD
Teniposide—Hyperhidrosis—Etoposide—sarcoma	3.43e-05	0.00157	CcSEcCtD
Teniposide—Urticaria—Mitoxantrone—sarcoma	3.39e-05	0.00155	CcSEcCtD
Teniposide—Anorexia—Etoposide—sarcoma	3.38e-05	0.00155	CcSEcCtD
Teniposide—Diarrhoea—Thiotepa—sarcoma	3.38e-05	0.00155	CcSEcCtD
Teniposide—Body temperature increased—Mitoxantrone—sarcoma	3.37e-05	0.00155	CcSEcCtD
Teniposide—Abdominal pain—Mitoxantrone—sarcoma	3.37e-05	0.00155	CcSEcCtD
Teniposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	3.36e-05	0.00278	CbGpPWpGaD
Teniposide—Diarrhoea—Dactinomycin—sarcoma	3.35e-05	0.00154	CcSEcCtD
Teniposide—Pancytopenia—Epirubicin—sarcoma	3.32e-05	0.00152	CcSEcCtD
Teniposide—Hypotension—Etoposide—sarcoma	3.32e-05	0.00152	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—JUN—sarcoma	3.31e-05	0.00274	CbGpPWpGaD
Teniposide—Neutropenia—Epirubicin—sarcoma	3.27e-05	0.0015	CcSEcCtD
Teniposide—NCOA1—Adipogenesis—CTNNB1—sarcoma	3.24e-05	0.00268	CbGpPWpGaD
Teniposide—Hypersensitivity—Vincristine—sarcoma	3.23e-05	0.00148	CcSEcCtD
Teniposide—NCOA1—Leptin signaling pathway—HRAS—sarcoma	3.2e-05	0.00265	CbGpPWpGaD
Teniposide—Dyspnoea—Etoposide—sarcoma	3.16e-05	0.00145	CcSEcCtD
Teniposide—Hypersensitivity—Mitoxantrone—sarcoma	3.14e-05	0.00144	CcSEcCtD
Teniposide—Asthenia—Vincristine—sarcoma	3.14e-05	0.00144	CcSEcCtD
Teniposide—Vomiting—Thiotepa—sarcoma	3.14e-05	0.00144	CcSEcCtD
Teniposide—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	3.13e-05	0.00259	CbGpPWpGaD
Teniposide—Vomiting—Dactinomycin—sarcoma	3.12e-05	0.00143	CcSEcCtD
Teniposide—Rash—Thiotepa—sarcoma	3.11e-05	0.00143	CcSEcCtD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—TP53—sarcoma	3.11e-05	0.00258	CbGpPWpGaD
Teniposide—Dermatitis—Thiotepa—sarcoma	3.11e-05	0.00143	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—PTPRC—sarcoma	3.1e-05	0.00256	CbGpPWpGaD
Teniposide—Headache—Thiotepa—sarcoma	3.09e-05	0.00142	CcSEcCtD
Teniposide—Rash—Dactinomycin—sarcoma	3.09e-05	0.00142	CcSEcCtD
Teniposide—Decreased appetite—Etoposide—sarcoma	3.08e-05	0.00141	CcSEcCtD
Teniposide—Pancytopenia—Doxorubicin—sarcoma	3.07e-05	0.00141	CcSEcCtD
Teniposide—ABCG2—lymph node—sarcoma	3.07e-05	0.00334	CbGeAlD
Teniposide—Asthenia—Mitoxantrone—sarcoma	3.06e-05	0.0014	CcSEcCtD
Teniposide—Neuropathy peripheral—Epirubicin—sarcoma	3.06e-05	0.0014	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—VEGFA—sarcoma	3.06e-05	0.00253	CbGpPWpGaD
Teniposide—Stomatitis—Epirubicin—sarcoma	3.04e-05	0.00139	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—PLCG1—sarcoma	3.03e-05	0.00251	CbGpPWpGaD
Teniposide—Neutropenia—Doxorubicin—sarcoma	3.03e-05	0.00139	CcSEcCtD
Teniposide—Diarrhoea—Vincristine—sarcoma	3e-05	0.00137	CcSEcCtD
Teniposide—Sweating—Epirubicin—sarcoma	2.99e-05	0.00137	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—SRC—sarcoma	2.97e-05	0.00245	CbGpPWpGaD
Teniposide—Nausea—Thiotepa—sarcoma	2.93e-05	0.00134	CcSEcCtD
Teniposide—Feeling abnormal—Etoposide—sarcoma	2.92e-05	0.00134	CcSEcCtD
Teniposide—Diarrhoea—Mitoxantrone—sarcoma	2.92e-05	0.00134	CcSEcCtD
Teniposide—Nausea—Dactinomycin—sarcoma	2.91e-05	0.00133	CcSEcCtD
Teniposide—Gastrointestinal pain—Etoposide—sarcoma	2.9e-05	0.00133	CcSEcCtD
Teniposide—Neuropathy peripheral—Doxorubicin—sarcoma	2.83e-05	0.0013	CcSEcCtD
Teniposide—Urticaria—Etoposide—sarcoma	2.82e-05	0.00129	CcSEcCtD
Teniposide—Haemoglobin—Epirubicin—sarcoma	2.81e-05	0.00129	CcSEcCtD
Teniposide—Stomatitis—Doxorubicin—sarcoma	2.81e-05	0.00129	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—MYC—sarcoma	2.81e-05	0.00233	CbGpPWpGaD
Teniposide—Body temperature increased—Etoposide—sarcoma	2.81e-05	0.00129	CcSEcCtD
Teniposide—Abdominal pain—Etoposide—sarcoma	2.81e-05	0.00129	CcSEcCtD
Teniposide—Haemorrhage—Epirubicin—sarcoma	2.8e-05	0.00128	CcSEcCtD
Teniposide—CYP3A4—liver—sarcoma	2.79e-05	0.00304	CbGeAlD
Teniposide—Vomiting—Vincristine—sarcoma	2.79e-05	0.00128	CcSEcCtD
Teniposide—Sweating—Doxorubicin—sarcoma	2.77e-05	0.00127	CcSEcCtD
Teniposide—Rash—Vincristine—sarcoma	2.76e-05	0.00127	CcSEcCtD
Teniposide—Dermatitis—Vincristine—sarcoma	2.76e-05	0.00126	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—EGFR—sarcoma	2.75e-05	0.00228	CbGpPWpGaD
Teniposide—Headache—Vincristine—sarcoma	2.74e-05	0.00126	CcSEcCtD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—sarcoma	2.74e-05	0.00227	CbGpPWpGaD
Teniposide—Vomiting—Mitoxantrone—sarcoma	2.71e-05	0.00124	CcSEcCtD
Teniposide—ABCG2—HIF-2-alpha transcription factor network—VEGFA—sarcoma	2.69e-05	0.00223	CbGpPWpGaD
Teniposide—Rash—Mitoxantrone—sarcoma	2.69e-05	0.00123	CcSEcCtD
Teniposide—Dermatitis—Mitoxantrone—sarcoma	2.69e-05	0.00123	CcSEcCtD
Teniposide—Headache—Mitoxantrone—sarcoma	2.67e-05	0.00122	CcSEcCtD
Teniposide—TOP2A—Cell Cycle, Mitotic—STAG1—sarcoma	2.64e-05	0.00218	CbGpPWpGaD
Teniposide—Hypersensitivity—Etoposide—sarcoma	2.61e-05	0.0012	CcSEcCtD
Teniposide—Haemoglobin—Doxorubicin—sarcoma	2.6e-05	0.00119	CcSEcCtD
Teniposide—Nausea—Vincristine—sarcoma	2.6e-05	0.00119	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—EGFR—sarcoma	2.6e-05	0.00215	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—FOXO1—sarcoma	2.6e-05	0.00215	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—KRAS—sarcoma	2.6e-05	0.00215	CbGpPWpGaD
Teniposide—Flushing—Epirubicin—sarcoma	2.6e-05	0.00119	CcSEcCtD
Teniposide—Haemorrhage—Doxorubicin—sarcoma	2.59e-05	0.00119	CcSEcCtD
Teniposide—TOP2A—Vinblastine—Vincristine—sarcoma	2.57e-05	0.0342	CbGdCrCtD
Teniposide—Asthenia—Etoposide—sarcoma	2.55e-05	0.00117	CcSEcCtD
Teniposide—Nausea—Mitoxantrone—sarcoma	2.53e-05	0.00116	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—CREB1—sarcoma	2.52e-05	0.00208	CbGpPWpGaD
Teniposide—Chills—Epirubicin—sarcoma	2.51e-05	0.00115	CcSEcCtD
Teniposide—Pruritus—Etoposide—sarcoma	2.51e-05	0.00115	CcSEcCtD
Teniposide—Arrhythmia—Epirubicin—sarcoma	2.5e-05	0.00115	CcSEcCtD
Teniposide—Alopecia—Epirubicin—sarcoma	2.47e-05	0.00113	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—KRAS—sarcoma	2.46e-05	0.00203	CbGpPWpGaD
Teniposide—Diarrhoea—Etoposide—sarcoma	2.43e-05	0.00111	CcSEcCtD
Teniposide—Flushing—Doxorubicin—sarcoma	2.4e-05	0.0011	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	2.39e-05	0.00198	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—sarcoma	2.39e-05	0.00198	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—STAG1—sarcoma	2.36e-05	0.00195	CbGpPWpGaD
Teniposide—Chills—Doxorubicin—sarcoma	2.32e-05	0.00106	CcSEcCtD
Teniposide—Arrhythmia—Doxorubicin—sarcoma	2.31e-05	0.00106	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—TP53—sarcoma	2.31e-05	0.00191	CbGpPWpGaD
Teniposide—Alopecia—Doxorubicin—sarcoma	2.29e-05	0.00105	CcSEcCtD
Teniposide—Vomiting—Etoposide—sarcoma	2.26e-05	0.00103	CcSEcCtD
Teniposide—Anaemia—Epirubicin—sarcoma	2.25e-05	0.00103	CcSEcCtD
Teniposide—Agitation—Epirubicin—sarcoma	2.24e-05	0.00103	CcSEcCtD
Teniposide—Rash—Etoposide—sarcoma	2.24e-05	0.00103	CcSEcCtD
Teniposide—Dermatitis—Etoposide—sarcoma	2.24e-05	0.00102	CcSEcCtD
Teniposide—Headache—Etoposide—sarcoma	2.22e-05	0.00102	CcSEcCtD
Teniposide—Leukopenia—Epirubicin—sarcoma	2.18e-05	0.001	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—FOXO1—sarcoma	2.15e-05	0.00178	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—KDR—sarcoma	2.15e-05	0.00178	CbGpPWpGaD
Teniposide—Nausea—Etoposide—sarcoma	2.11e-05	0.000966	CcSEcCtD
Teniposide—Hypertension—Epirubicin—sarcoma	2.1e-05	0.000964	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—HRAS—sarcoma	2.09e-05	0.00173	CbGpPWpGaD
Teniposide—Anaemia—Doxorubicin—sarcoma	2.08e-05	0.000955	CcSEcCtD
Teniposide—ABCG2—Fluoropyrimidine Activity—TP53—sarcoma	2.08e-05	0.00172	CbGpPWpGaD
Teniposide—Chest pain—Epirubicin—sarcoma	2.08e-05	0.000951	CcSEcCtD
Teniposide—Agitation—Doxorubicin—sarcoma	2.07e-05	0.000949	CcSEcCtD
Teniposide—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	2.06e-05	0.00171	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—NPM1—sarcoma	2.02e-05	0.00167	CbGpPWpGaD
Teniposide—Leukopenia—Doxorubicin—sarcoma	2.02e-05	0.000925	CcSEcCtD
Teniposide—Confusional state—Epirubicin—sarcoma	2.01e-05	0.000919	CcSEcCtD
Teniposide—Oedema—Epirubicin—sarcoma	1.99e-05	0.000911	CcSEcCtD
Teniposide—Infection—Epirubicin—sarcoma	1.98e-05	0.000905	CcSEcCtD
Teniposide—Thrombocytopenia—Epirubicin—sarcoma	1.95e-05	0.000892	CcSEcCtD
Teniposide—Hypertension—Doxorubicin—sarcoma	1.95e-05	0.000892	CcSEcCtD
Teniposide—TOP2A—Idarubicin—Epirubicin—sarcoma	1.94e-05	0.0259	CbGdCrCtD
Teniposide—TOP2A—Doxorubicin—Epirubicin—sarcoma	1.94e-05	0.0259	CbGdCrCtD
Teniposide—TOP2A—Daunorubicin—Epirubicin—sarcoma	1.94e-05	0.0259	CbGdCrCtD
Teniposide—Tachycardia—Epirubicin—sarcoma	1.94e-05	0.000889	CcSEcCtD
Teniposide—Hyperhidrosis—Epirubicin—sarcoma	1.92e-05	0.000881	CcSEcCtD
Teniposide—Chest pain—Doxorubicin—sarcoma	1.92e-05	0.00088	CcSEcCtD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—MYC—sarcoma	1.92e-05	0.00159	CbGpPWpGaD
Teniposide—Anorexia—Epirubicin—sarcoma	1.9e-05	0.000869	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—CREB1—sarcoma	1.89e-05	0.00156	CbGpPWpGaD
Teniposide—Hypotension—Epirubicin—sarcoma	1.86e-05	0.000852	CcSEcCtD
Teniposide—Confusional state—Doxorubicin—sarcoma	1.86e-05	0.00085	CcSEcCtD
Teniposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	1.85e-05	0.00153	CbGpPWpGaD
Teniposide—Oedema—Doxorubicin—sarcoma	1.84e-05	0.000843	CcSEcCtD
Teniposide—Infection—Doxorubicin—sarcoma	1.83e-05	0.000838	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—JUN—sarcoma	1.81e-05	0.0015	CbGpPWpGaD
Teniposide—Thrombocytopenia—Doxorubicin—sarcoma	1.8e-05	0.000826	CcSEcCtD
Teniposide—TOP2A—Idarubicin—Doxorubicin—sarcoma	1.8e-05	0.024	CbGdCrCtD
Teniposide—TOP2A—Daunorubicin—Doxorubicin—sarcoma	1.8e-05	0.024	CbGdCrCtD
Teniposide—TOP2A—Epirubicin—Doxorubicin—sarcoma	1.8e-05	0.024	CbGdCrCtD
Teniposide—Tachycardia—Doxorubicin—sarcoma	1.8e-05	0.000823	CcSEcCtD
Teniposide—Hyperhidrosis—Doxorubicin—sarcoma	1.78e-05	0.000815	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—KDR—sarcoma	1.78e-05	0.00147	CbGpPWpGaD
Teniposide—Dyspnoea—Epirubicin—sarcoma	1.77e-05	0.000812	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	1.77e-05	0.00146	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—MMP2—sarcoma	1.75e-05	0.00145	CbGpPWpGaD
Teniposide—Anorexia—Doxorubicin—sarcoma	1.75e-05	0.000804	CcSEcCtD
Teniposide—Decreased appetite—Epirubicin—sarcoma	1.73e-05	0.000792	CcSEcCtD
Teniposide—Hypotension—Doxorubicin—sarcoma	1.72e-05	0.000788	CcSEcCtD
Teniposide—NCOA3—Metabolism—ENO2—sarcoma	1.72e-05	0.00142	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—HBA1—sarcoma	1.71e-05	0.00141	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—CREB1—sarcoma	1.7e-05	0.0014	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CCND1—sarcoma	1.68e-05	0.00139	CbGpPWpGaD
Teniposide—Dyspnoea—Doxorubicin—sarcoma	1.64e-05	0.000752	CcSEcCtD
Teniposide—Feeling abnormal—Epirubicin—sarcoma	1.64e-05	0.000751	CcSEcCtD
Teniposide—Gastrointestinal pain—Epirubicin—sarcoma	1.63e-05	0.000745	CcSEcCtD
Teniposide—Decreased appetite—Doxorubicin—sarcoma	1.6e-05	0.000733	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	1.58e-05	0.00131	CbGpPWpGaD
Teniposide—Urticaria—Epirubicin—sarcoma	1.58e-05	0.000724	CcSEcCtD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—sarcoma	1.57e-05	0.0013	CbGpPWpGaD
Teniposide—Body temperature increased—Epirubicin—sarcoma	1.57e-05	0.00072	CcSEcCtD
Teniposide—Abdominal pain—Epirubicin—sarcoma	1.57e-05	0.00072	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—CREB1—sarcoma	1.56e-05	0.00129	CbGpPWpGaD
Teniposide—Feeling abnormal—Doxorubicin—sarcoma	1.52e-05	0.000695	CcSEcCtD
Teniposide—Gastrointestinal pain—Doxorubicin—sarcoma	1.51e-05	0.00069	CcSEcCtD
Teniposide—Hypersensitivity—Epirubicin—sarcoma	1.47e-05	0.000671	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	1.46e-05	0.00121	CbGpPWpGaD
Teniposide—Urticaria—Doxorubicin—sarcoma	1.46e-05	0.00067	CcSEcCtD
Teniposide—NCOA3—Metabolism—PLCG1—sarcoma	1.46e-05	0.0012	CbGpPWpGaD
Teniposide—Body temperature increased—Doxorubicin—sarcoma	1.46e-05	0.000667	CcSEcCtD
Teniposide—Abdominal pain—Doxorubicin—sarcoma	1.46e-05	0.000667	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—MMP2—sarcoma	1.45e-05	0.0012	CbGpPWpGaD
Teniposide—Asthenia—Epirubicin—sarcoma	1.43e-05	0.000654	CcSEcCtD
Teniposide—NCOA1—Metabolism—ENO2—sarcoma	1.42e-05	0.00117	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—HBA1—sarcoma	1.41e-05	0.00117	CbGpPWpGaD
Teniposide—Pruritus—Epirubicin—sarcoma	1.41e-05	0.000645	CcSEcCtD
Teniposide—Diarrhoea—Epirubicin—sarcoma	1.36e-05	0.000624	CcSEcCtD
Teniposide—Hypersensitivity—Doxorubicin—sarcoma	1.36e-05	0.000621	CcSEcCtD
Teniposide—TOP2A—Mitotic G1-G1/S phases—MYC—sarcoma	1.35e-05	0.00112	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—CTNNB1—sarcoma	1.35e-05	0.00111	CbGpPWpGaD
Teniposide—Asthenia—Doxorubicin—sarcoma	1.32e-05	0.000605	CcSEcCtD
Teniposide—Pruritus—Doxorubicin—sarcoma	1.3e-05	0.000597	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.27e-05	0.00105	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.27e-05	0.00105	CbGpPWpGaD
Teniposide—Vomiting—Epirubicin—sarcoma	1.26e-05	0.000579	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.26e-05	0.00104	CbGpPWpGaD
Teniposide—Diarrhoea—Doxorubicin—sarcoma	1.26e-05	0.000577	CcSEcCtD
Teniposide—Rash—Epirubicin—sarcoma	1.25e-05	0.000575	CcSEcCtD
Teniposide—Dermatitis—Epirubicin—sarcoma	1.25e-05	0.000574	CcSEcCtD
Teniposide—Headache—Epirubicin—sarcoma	1.25e-05	0.000571	CcSEcCtD
Teniposide—TOP2A—Circadian rythm related genes—JUN—sarcoma	1.22e-05	0.00101	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—SRC—sarcoma	1.22e-05	0.00101	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PLCG1—sarcoma	1.21e-05	0.000997	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—VEGFA—sarcoma	1.18e-05	0.00098	CbGpPWpGaD
Teniposide—Nausea—Epirubicin—sarcoma	1.18e-05	0.000541	CcSEcCtD
Teniposide—Vomiting—Doxorubicin—sarcoma	1.17e-05	0.000536	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—NRAS—sarcoma	1.17e-05	0.000968	CbGpPWpGaD
Teniposide—Rash—Doxorubicin—sarcoma	1.16e-05	0.000532	CcSEcCtD
Teniposide—Dermatitis—Doxorubicin—sarcoma	1.16e-05	0.000531	CcSEcCtD
Teniposide—Headache—Doxorubicin—sarcoma	1.15e-05	0.000528	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.14e-05	0.000943	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—CTNNB1—sarcoma	1.11e-05	0.00092	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.11e-05	0.000919	CbGpPWpGaD
Teniposide—Nausea—Doxorubicin—sarcoma	1.09e-05	0.000501	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—EGFR—sarcoma	1.07e-05	0.000882	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.02e-05	0.000845	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—KRAS—sarcoma	1.01e-05	0.000833	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—SRC—sarcoma	1.01e-05	0.000832	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	9.99e-06	0.000827	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—VEGFA—sarcoma	9.8e-06	0.00081	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—NRAS—sarcoma	9.68e-06	0.0008	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—MYC—sarcoma	9.58e-06	0.000792	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	9.44e-06	0.000781	CbGpPWpGaD
Teniposide—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	9.27e-06	0.000766	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—EGFR—sarcoma	8.82e-06	0.000729	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—HRAS—sarcoma	8.56e-06	0.000708	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	8.39e-06	0.000694	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—KRAS—sarcoma	8.33e-06	0.000689	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—TP53—sarcoma	8.06e-06	0.000666	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—HRAS—sarcoma	7.08e-06	0.000586	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MDM2—sarcoma	6.33e-06	0.000524	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CCND1—sarcoma	6.17e-06	0.00051	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CCND1—sarcoma	5.51e-06	0.000456	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—MYC—sarcoma	4.95e-06	0.000409	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—MYC—sarcoma	4.61e-06	0.000381	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—ENO2—sarcoma	4.58e-06	0.000379	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—HBA1—sarcoma	4.56e-06	0.000377	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MYC—sarcoma	4.42e-06	0.000366	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PLCG1—sarcoma	3.89e-06	0.000322	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TP53—sarcoma	3.63e-06	0.0003	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—ENO2—sarcoma	3.28e-06	0.000272	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—HBA1—sarcoma	3.26e-06	0.00027	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PLCG1—sarcoma	2.79e-06	0.000231	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—ENO2—sarcoma	2.54e-06	0.00021	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—HBA1—sarcoma	2.52e-06	0.000209	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—ENO2—sarcoma	2.32e-06	0.000192	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—HBA1—sarcoma	2.3e-06	0.00019	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PLCG1—sarcoma	2.15e-06	0.000178	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PLCG1—sarcoma	1.96e-06	0.000163	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—ENO2—sarcoma	1.53e-06	0.000126	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—HBA1—sarcoma	1.52e-06	0.000126	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PLCG1—sarcoma	1.3e-06	0.000107	CbGpPWpGaD
